A logo

Agilent Technologies, Inc. Stock Price

NYSE:A Community·US$39.9b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 38 Fair Values set on narratives written by author

A Share Price Performance

US$140.11
-2.63 (-1.84%)
0.6% undervalued intrinsic discount
US$140.97
Fair Value
US$140.11
-2.63 (-1.84%)
0.6% undervalued intrinsic discount
US$140.97
Fair Value
Price US$140.11
AnalystConsensusTarget US$140.97

A Community Narratives

AnalystConsensusTarget·
Fair Value US$140.97 0.1% undervalued intrinsic discount

Global Healthcare Demand And PFAS Testing Will Drive Analytical Progress

0users have liked this narrative
0users have commented on this narrative
24users have followed this narrative

Recent A News & Updates

Agilent: Growth Across All Segments, But Investors Will Need To Be Patient

Aug 28

Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Aug 03
Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies, Inc. Key Details

US$6.8b

Revenue

US$3.2b

Cost of Revenue

US$3.6b

Gross Profit

US$2.3b

Other Expenses

US$1.2b

Earnings

Last Reported Earnings
Jul 31, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
4.30
Gross Margin
52.58%
Net Profit Margin
17.97%
Debt/Equity Ratio
53.5%

Agilent Technologies, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet with limited growth.

0 Risks
2 Rewards

About A

Founded
1999
Employees
18000
CEO
Padraig McDonnell
WebsiteView website
www.agilent.com

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. This segment also offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies. The Diagnostics and Genomics segment provides genomics, contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses; and cell analysis plate based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, and related consumables. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

U.S. Market Performance

  • 7 Days: 0.3%
  • 3 Months: 8.5%
  • 1 Year: 17.3%
  • Year to Date: 15.0%
The market has stayed flat over the 7 days. As for the longer term, the market has risen 17% in the past 12 months. Earnings are forecast to grow by 15% annually. Market details ›